Dr. Rachid Karam explains how RNA testing increases diagnostic yield and reduces variants of uncertain significance in cancer and exomes.
All tagged ambry
Dr. Rachid Karam explains how RNA testing increases diagnostic yield and reduces variants of uncertain significance in cancer and exomes.
The “Patient For Life” exome reanalysis program is explored with Ambry Genetics’ Chief Medical Officer, Dr. Elizabeth Chao, and the VP of Medical Affairs and a seasoned Genetic Counselor, Kelly Hagman.